4-butyrolactone has been researched along with Coronary Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, AT; Franke, AA; Hu, FB; Hu, Y; Li, J; Li, Y; Liang, L; Liu, G; Mukamal, KJ; Rimm, EB; Sun, Q | 1 |
| Alfthan, G; Ariniemi, K; Erlund, I; Kilkkinen, A; Virtamo, J; Virtanen, MJ | 1 |
| Bonnet, F; Gilbert, R | 1 |
| Adlercreutz, H; Kaikkonen, J; Morrow, JD; Nurmi, T; Roberts, LJ; Salonen, JT; Vanharanta, M; Voutilainen, S | 1 |
1 trial(s) available for 4-butyrolactone and Coronary Disease
| Article | Year |
|---|---|
Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers.
Topics: 4-Butyrolactone; Aged; alpha-Tocopherol; beta Carotene; Biomarkers; Case-Control Studies; Coronary Disease; Finland; Humans; Lignans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Smoking | 2006 |
3 other study(ies) available for 4-butyrolactone and Coronary Disease
| Article | Year |
|---|---|
Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.
Topics: 4-Butyrolactone; Adult; Case-Control Studies; Coronary Disease; Diet; Female; Gastrointestinal Microbiome; Humans; Lignans; Male; Methylamines; Prospective Studies; Risk Factors; United States | 2021 |
Enterolactone and coronary events.
Topics: 4-Butyrolactone; Coronary Disease; Diabetes Mellitus; Estrogens; Humans; Lignans; Risk Assessment | 2000 |
Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation.
Topics: 4-Butyrolactone; Coronary Disease; Estrogens; F2-Isoprostanes; Homocysteine; Humans; Lignans; Lipid Peroxidation; Male; Middle Aged; Multivariate Analysis; Risk Factors | 2002 |